SynthesisTexas Heart Institute journal2010

Lipoprotein-associated phospholipase A2 as a novel risk marker for cardiovascular disease: a systematic review of the literature.

Mohammad Madjid et al.PubMed ↗Full text ↗

No numbers read from the abstract.